Location: Home
  • search
  • go
  • Relate News
  • 7/6/2020NPC Solicits Comments on 2nd Draft of the Chinese Patent Law Amendment...
  • 7/3/2020CDE Issues Interim Guidelines for Registration Acceptance and Evaluati...
  • 7/3/2020GSK Launches Shingles Vaccines Shingrix in China
  • 7/3/2020Boehringer Ingelheim Launches Innovation Hub in Shanghai
  • 7/2/2020NMPA and NHC Introduce the 2020 Edition of Chinese Pharmacopoeia
  • 7/2/2020NIFDC Issues the Guideline for the Working Procedures and Technical Re...
  • 7/2/2020Senior Chinese Pharma Official Investigated for Serious Legal Violatio...
  • 7/2/2020NMPA Issues the Amended Blood Product Appendix of 2010 GMP
  • 7/1/2020Revisiting the Basis of Your China Strategy in the Post-Covid New Norm...
  • 7/1/2020Trends in U.S. Multinational Enterprise Activity in China, 2000-2017
  • 7/1/2020CDE Solicits Comments on the Draft CDE Guidelines for Management of Su...
  • 7/1/2020CDE Issues the M4 Module 1. Administrative Information and Prescribing...
  • 7/1/2020CDE Issues the Guidelines for Evaluation and Management of Safety Info...
  • 7/1/2020CDE Issues the Guidelines for Clinical Trial Registration and Informat...
  • 7/1/2020NMPA Reports on Crackdown of Fake and Substandard Drugs in 2019
  • 7/1/2020China's First COVID-19 mRNA Vaccine Approved for Clinical Trials
  • 7/1/2020Financial-related Company News in Brief
  • 7/1/2020ObsEva and Yuyuan Bio Announce Submission of Chinese Pre-IND Dossier f...
  • 7/1/2020NMPA Issues Announcement on Drug Registration Fee Standards and Rules
  • 7/1/2020NMPA Issues the Requirements for Drug Record and Data Management (Inte...
  • 7/1/2020CDE Issues the Guidelines for Safety Update Reporting During R&D (Inte...
  • 6/30/2020BeiGene Launches Amgen's XGEVA (Denosumab) in China
  • 6/30/2020Recent Executive Movements
  • 6/30/2020NMPA Issues the Chemical Drug Registration Classification and Dossier ...
  • 6/30/2020NMPA Issues the Biologic Product Registration Classification and Dossi...
  • 6/30/2020NMPA Publicizes the List of Reference Formulations for Generic Drug Eq...
  • 6/30/2020Fitch: No Near-Term Impact on Chinese API Makers as Pharma Supply-Chai...
  • 6/30/2020Ex-USPTO Head, Retired Judge Back China Pharma IP Reform
  • 6/30/2020Helsinn Announces Launch of Oral Formulation of Akynzeo in China
  • 6/30/2020How Data Protection Matters for Pharma Cos in Mainland China? - Ensuri...
  • Page:258/801 Total number of articles:24028: [First][<<] [256] [257] [258] [259] [260] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group